Listen to our Transplant Radio interview series, Part 2 of 10 from ATC 2024 in Philadelphia, PA. We exhibited as our Eurofins Transplant group, which is comprised of Eurofins Viracor, Eurofins Transplant Genomics, Eurofins Donor & Product Testing (DPT), Eurofins CellTx, and Ascend Clinical. Kevin Foth and Eurofins Transplant Genomics Chief Medical Officer, Jon Friedman, MD, FAST. Episode Links: Learn more about Eurofins Transplant Diagnostics. Social Media: Linkedin | X-Twitter | Facebook | Threads | YouTube | Bluesky For more information visit: Eurofins-Viracor.com or call (800)305-5198 Copyright © 2025 Eurofins Viracor, LLC. All Rights Reserved. 🎧 Home of Transplant Radio™

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related